Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.023 | 0.7 |
mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |